Metraipolis › archive › dc_eafaa47cb5b5
Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer — Europe PMC PMID:41814321
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41814321
- DOI
- 10.1186/s13046-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T13:26:33.436Z
- SHA-256 of the archived text
c7909fc60e9e2b97b411072a0244a1d3d58fff1fdaf6718d2d26d807cbca2094- Stable URL of this page
https://metraipolis.com/documento/dc_eafaa47cb5b5
How to cite
Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer — Europe PMC PMID:41814321 — Europe PMC (en), https://europepmc.org/article/MED/41814321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eafaa47cb5b5 (Metraipolis archive dc_eafaa47cb5b5, sha256 c7909fc60e9e2b97b411072a0244a1d3d58fff1fdaf6718d2d26d807cbca2094)
BibTeX
@misc{dceafaa47cb5b5,
title = {Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer — Europe PMC PMID:41814321},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41814321},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eafaa47cb5b5; sha256 c7909fc60e9e2b97b411072a0244a1d3d58fff1fdaf6718d2d26d807cbca2094},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41814321. Agents can read the archived copy with the MCP tool read_document.